{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T04:10:44Z","timestamp":1794975044395,"version":"4.9.1"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22107050"],"award-info":[{"award-number":["22107050"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22377053"],"award-info":[{"award-number":["22377053"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ejmech.2024.117077","type":"journal-article","created":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T15:40:43Z","timestamp":1731858043000},"page":"117077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["DNA or not DNA \u2014that is the question determining the design of platinum anticancer drugs"],"prefix":"10.1016","volume":"282","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6333-322X","authenticated-orcid":false,"given":"Suxing","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8338-9773","authenticated-orcid":false,"given":"Xiaoyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.117077_bib1","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1200\/JCO.2015.60.7481","article-title":"Platinum antitumor complexes: 50 years since barnett Rosenberg's discovery","volume":"33","author":"Muggia","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2024.117077_bib2","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1126\/science.1150504","article-title":"Metal-based therapeutics","volume":"318","author":"Hambley","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2024.117077_bib3","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/205698a0","article-title":"Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode","volume":"205","author":"Rosenberg","year":"1965","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.117077_bib4","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1021\/cr400460s","article-title":"Metallodrugs in medicinal inorganic chemistry","volume":"114","author":"Mjos","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.117077_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41568-020-00308-y","article-title":"The rediscovery of platinum-based cancer therapy","volume":"21","author":"Rottenberg","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2024.117077_bib6","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1021\/acs.chemrev.8b00209","article-title":"Stimuli-responsive therapeutic metallodrugs","volume":"119","author":"Wang","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.117077_bib7","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.ccr.2009.01.028","article-title":"Mechanistic insight into the cellular uptake and processing of cisplatin 30 years after its approval by FDA","volume":"253","author":"Arnesano","year":"2009","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.117077_bib8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd1691","article-title":"Cellular processing of platinum anticancer drugs","volume":"4","author":"Wang","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.117077_bib9","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1021\/acs.chemrev.5b00597","article-title":"The next generation of platinum drugs: targeted Pt(II) agents, nanoparticle delivery, and Pt(IV) prodrugs","volume":"116","author":"Johnstone","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.117077_bib10","doi-asserted-by":"crossref","first-page":"12234","DOI":"10.1021\/ic400538c","article-title":"Monofunctional and higher-valent platinum anticancer agents","volume":"52","author":"Johnstone","year":"2013","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.trechm.2021.03.006","article-title":"Metal complexes for therapeutic applications","volume":"3","author":"Karges","year":"2021","journal-title":"Trends Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/cnma.202300295","article-title":"Chemical and photophysical triggers for the reduction of Pt(IV) prodrugs for anticancer therapy","volume":"9","author":"Karges","year":"2023","journal-title":"ChemNanoMat"},{"key":"10.1016\/j.ejmech.2024.117077_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.137366","article-title":"Platinum-based drugs in cancer treatment: expanding horizons and overcoming resistance","volume":"1301","author":"Shahlaei","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2024.117077_bib14","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/nar\/27.8.1837","article-title":"Crystal structure of a double-stranded DNA containing a cisplatin interstrand cross-link at 1.63 \u00c5 resolution: hydration at the platinated site","volume":"27","author":"Coste","year":"1999","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2024.117077_bib15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/0929867033368484","article-title":"Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways","volume":"10","author":"Fuertes","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib16","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00280-016-2976-z","article-title":"Platinum-based drugs: past, present and future","volume":"77","author":"Dilruba","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.117077_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/187152007779314062","article-title":"The role of sulfur in platinum anticancer chemotherapy","volume":"7","author":"Wang","year":"2007","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib18","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1039\/C8DT00838H","article-title":"The side effects of platinum-based chemotherapy drugs: a review for chemists","volume":"47","author":"Oun","year":"2018","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2024.117077_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0006-3061(00)80249-5","article-title":"Studies on the antitumor activity of group VIII transition metal complexes. Part I. Platinum(II) complexes","volume":"2","author":"Cleare","year":"1973","journal-title":"Bioinorg. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0006-3061(00)80249-5","article-title":"Antitumor activity of group VIII transition metal complexes. I. Platinum(II) complexes","volume":"2","author":"Cleare","year":"1973","journal-title":"Bioinorg. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ccr.2017.04.013","article-title":"Cytotoxic platinum coordination compounds. DNA binding agents","volume":"351","author":"Brabec","year":"2017","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.117077_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-74760-1_1","article-title":"Metal antitumor compounds: the mechanism of action of platinum complexes","volume":"10","author":"Johnson","year":"1989","journal-title":"Prog. Clin. Biochem. Med."},{"key":"10.1016\/j.ejmech.2024.117077_bib23","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/PL00000762","article-title":"Molecular mechanisms involved in cisplatin cytotoxicity","volume":"57","author":"Jordan","year":"2000","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2024.117077_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pharmthera.2012.07.003","article-title":"Subcellular targets of cisplatin cytotoxicity: an integrated view","volume":"136","author":"Sancho-Mart\u00ednez","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2024.117077_bib25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1021\/cr020010d","article-title":"Biochemical modulation of cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance","volume":"103","author":"Fuertes","year":"2003","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.117077_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/1389557024605500","article-title":"Biomolecular targets for platinum antitumor drugs","volume":"2","author":"Bose","year":"2002","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1039\/C3MT00357D","article-title":"Pt-based drugs: the spotlight will be on proteins","volume":"6","author":"Pinato","year":"2014","journal-title":"Metallomics"},{"key":"10.1016\/j.ejmech.2024.117077_bib28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s41061-023-00448-3","article-title":"Pt(IV) complexes in the search for novel platinum prodrugs with promising activity","volume":"382","author":"Aher","year":"2024","journal-title":"Top. Curr. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib29","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1021\/acs.chemrev.8b00396","article-title":"Metal drugs and the anticancer immune response","volume":"119","author":"Englinger","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.117077_bib30","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1039\/c2cc30952a","article-title":"Progress in artificial metallonucleases","volume":"48","author":"Mancin","year":"2012","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2024.117077_bib31","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.ccr.2011.12.005","article-title":"Copper(II), zinc(II) and nickel(II) complexes as nuclease mimetics","volume":"256","author":"Desbouis","year":"2012","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.117077_bib32","series-title":"Elsevier Reference Module in Chemistry, Molecular Sciences and Chemical Engineering","first-page":"413","article-title":"Advances in the development of DNA-cleaving metal complexes as anticancer agents","author":"Erxleben","year":"2015"},{"key":"10.1016\/j.ejmech.2024.117077_bib33","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ejmech.2017.09.034","article-title":"Research progress in modern structure of platinum complexes","volume":"140","author":"Bai","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/0929867053363414","article-title":"The search of DNA-intercalators as antitumoral drugs: what it worked and what did not work","volume":"12","author":"Mart\u00ednez","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib35","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1039\/b710949k","article-title":"Metallo-intercalators and metallo-insertors","volume":"28","author":"Zeglis","year":"2007","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2024.117077_bib36","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.1039\/b811723c","article-title":"In vivo studies of a platinum(II) metallointercalator","volume":"21","author":"Fisher","year":"2008","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2024.117077_bib37","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1073\/pnas.72.12.4825","article-title":"X-ray fiber diffraction evidence for neighbor exclusion binding of a platinum metallointercalation reagent to DNA","volume":"72","author":"Bond","year":"1975","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2024.117077_bib38","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bioorg.2019.03.009","article-title":"The comparative study of the DNA binding and biological activities of the quaternized dicnq as a dicationic form and its platinum(II) heteroleptic cationic complex","volume":"57","author":"Yildiz","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib39","doi-asserted-by":"crossref","first-page":"6880","DOI":"10.1039\/C5DT00728C","article-title":"New palladium(II) and platinum(II) 5,5-diethylbarbiturate complexes with 2-phenylpyridine, 2,2'-bipyridine and 2,2'-dipyridylamine: synthesis, structures, DNA binding, molecular docking, cellular uptake, antioxidant activity and cytotoxicity","volume":"44","author":"Icsel","year":"2015","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2024.117077_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2019.110749","article-title":"DNA-binding and in vitro cytotoxic activity of platinum(II) complexes of curcumin and caffeine","volume":"198","author":"Censi","year":"2019","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2024.117077_bib41","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1021\/ic00115a030","article-title":"Synthesis, characterization, and interaction with DNA of the novel metallointercalator cationic complex (2,2':6',2''-terpyridine) methylplatinum (II)","volume":"34","author":"Arena","year":"1995","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib42","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1039\/C8CS00157J","article-title":"Molecular methods for assessment of non-covalent metallodrug-DNA interactions","volume":"48","author":"Kellett","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2024.117077_bib43","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1073\/pnas.71.10.3839","article-title":"Metallointercalation reagents. 2-hydroxyethanethiolato(2,2',2'-terpyridine)-platinum(II) monocation binds strongly to DNA by intercalation","volume":"71","author":"Jennette","year":"1974","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2024.117077_bib44","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/276471a0","article-title":"Molecular structure of a double helical DNA fragment intercalator complex between deoxy CpG and a terpyridine platinum compound","volume":"276","author":"Wang","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.117077_bib45","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1039\/c3mt20252f","article-title":"A platinum complex that binds non-covalently to DNA and induces cell death via a different mechanism than cisplatin","volume":"5","author":"Suntharalingam","year":"2013","journal-title":"Metallomics"},{"key":"10.1016\/j.ejmech.2024.117077_bib46","doi-asserted-by":"crossref","first-page":"8716","DOI":"10.1039\/C8DT01254G","article-title":"A case of extensive protein platination: the reaction of lysozyme with a Pt(II)\u2013terpyridine complex","volume":"47","author":"Ferraro","year":"2018","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2024.117077_bib47","article-title":"The power of kinetic inertness in improving platinum anticancer therapy by circumventing resistance and ameliorating nephrotoxicity","volume":"62","author":"Panda","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2024.117077_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/aoc.6859","article-title":"Anticancer property and normal cell toxicity profile of pyrrolidine-based platinum(II) complexes: their DNA, BSA interaction, and molecular docking","volume":"36","author":"Tarai","year":"2022","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2022.111993","article-title":"Preparation, cytotoxic activity and DNA interaction studies of new platinum(II) complexes with 1,10-phenanthroline and 5-alkyl-1,3,4-oxadiazol-2(3H)-thione derivatives","volume":"237","author":"Souza","year":"2022","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2024.117077_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2021.214210","article-title":"What blocks more anticancer platinum complexes from experiment to clinic: major problems and potential strategies from drug design perspectives","volume":"449","author":"Peng","year":"2021","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.117077_bib51","doi-asserted-by":"crossref","first-page":"13474","DOI":"10.1093\/nar\/gku1157","article-title":"The phosphate clamp: sequence selective nucleic acid binding profiles and conformational induction of endonuclease inhibition by cationic triplatin complexes","volume":"42","author":"Prisecaru","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2024.117077_bib52","doi-asserted-by":"crossref","first-page":"16092","DOI":"10.1021\/ja062851y","article-title":"A third mode of DNA binding: phosphate clamps by a polynuclear platinum complex","volume":"128","author":"Komeda","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.117077_bib53","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00775-020-01817-9","article-title":"Molecular dynamics simulation of non-covalent interactions between polynuclear platinum(II) complexes and DNA","volume":"25","author":"Rosa","year":"2020","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib54","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1039\/c0cc01254h","article-title":"Excursions in polynuclear platinum DNA binding","volume":"46","author":"Mangrum","year":"2010","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2024.117077_bib55","doi-asserted-by":"crossref","first-page":"12812","DOI":"10.1002\/anie.201408012","article-title":"Substitution-inert trinuclear platinum complexes efficiently condense\/aggregate nucleic acids and inhibit enzymatic activity","volume":"53","author":"Malina","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2024.117077_bib56","doi-asserted-by":"crossref","first-page":"9598","DOI":"10.1021\/ic051390z","article-title":"Synthesis, characterization, and cytotoxicity of a novel highly charged trinuclear platinum compound. Enhancement of cellular uptake with charge","volume":"44","author":"Harris","year":"2005","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib57","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1124\/mol.105.018762","article-title":"Biological consequences of trinuclear platinum complexes: comparison of [{trans-PtCl(NH3)2}2\u03bc-(trans-Pt(NH3)2(H2N(CH2)6\u2012NH2)2)]4+ (BBR 3464) with its noncovalent congeners","volume":"69","author":"Harris","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.117077_bib58","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1351\/pac200779122243","article-title":"Metal-based anticancer drugs: from a past anchored in platinum chemistry to a post-genomic future of diverse chemistry and biology","volume":"79","author":"Hannon","year":"2007","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib59","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1021\/bi900389b","article-title":"Photoaffinity labeling reveals nuclear proteins that uniquely recognize cisplatin-DNA interstrand cross-links","volume":"48","author":"Zhu","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2024.117077_bib60","doi-asserted-by":"crossref","first-page":"6536","DOI":"10.1021\/ja049533o","article-title":"Identification of nuclear proteins that interact with platinum-modified DNA by photoaffinity labeling","volume":"126","author":"Zhang","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.117077_bib61","doi-asserted-by":"crossref","first-page":"21157","DOI":"10.1002\/anie.202009491","article-title":"A multi-action PtIV conjugate with oleate and cinnamate ligands targets human epithelial growth factor receptor HER2 in aggressive breast cancer cells","volume":"59","author":"Kostrhunova","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2024.117077_bib62","doi-asserted-by":"crossref","first-page":"8790","DOI":"10.1021\/ja5038269","article-title":"Pt(IV) prodrugs designed to bind non-covalently to human serum albumin for drug delivery","volume":"136","author":"Zheng","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.117077_bib63","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1021\/acs.jmedchem.7b00433","article-title":"Glycosylated platinum(IV) complexes as substrates for glucose transporters (GLUTs) and organic cation transporters (OCTs) exhibited cancer targeting and human serum albumin binding properties for drug delivery","volume":"60","author":"Ma","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib64","doi-asserted-by":"crossref","first-page":"7894","DOI":"10.1021\/acs.jmedchem.3c00269","article-title":"Platinum(IV) derivatives of [Pt(1S,2S-diaminocyclohexane)(5,6-dimethyl-1,10-phenanthroline)] with diclofenac ligands in the axial positions: a new class of potent multi-action agents exhibiting selectivity to cancer cells","volume":"66","author":"Kostrhunova","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202216917","article-title":"Disruption of zinc homeostasis by a novel platinum(IV)-terthiophene complex for antitumor immunity","volume":"62","author":"Su","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2024.117077_bib66","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.canlet.2014.07.023","article-title":"Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy","volume":"353","author":"Sullivan","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2024.117077_bib67","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1021\/acs.chemrev.8b00271","article-title":"Toward multi-targeted platinum and ruthenium drugs-a new paradigm in cancer drug treatment regimens?","volume":"119","author":"Kenny","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.117077_bib68","doi-asserted-by":"crossref","first-page":"18556","DOI":"10.1002\/anie.202005362","article-title":"CAIXplatins: highly potent platinum(IV) prodrugs selective against carbonic anhydrase IX for the treatment of hypoxic tumors","volume":"59","author":"Cao","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2024.117077_bib69","article-title":"Multitargeted platinum(IV) anticancer complexes bearing pyridinyl ligands as axial leaving groups","volume":"62","author":"Zhou","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2024.117077_bib70","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1039\/D0SC00197J","article-title":"Interfering in apoptosis and DNA repair of cancer cells to conquer cisplatin resistance by platinum(IV) prodrugs","volume":"11","author":"Zhang","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2024.117077_bib71","article-title":"Overcoming cancer resistance to platinum drugs by inhibiting cholesterol metabolism","volume":"62","author":"Wang","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2024.117077_bib72","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jinorgbio.2007.12.022","article-title":"Biophysical characterisation of adducts formed between anticancer metallodrugs and selected proteins: new insights from X-ray diffraction and mass spectrometry studies","volume":"102","author":"Casini","year":"2008","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2024.117077_bib73","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1021\/cr040704h","article-title":"Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology","volume":"106","author":"Timerbaev","year":"2006","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.117077_bib74","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1021\/acs.accounts.5b00322","article-title":"Multifunctional Pt(II) reagents: covalent modifications of Pt complexes enable diverse structural variation and in-cell detection","volume":"49","author":"White","year":"2016","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2024.117077_bib75","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1039\/B603833F","article-title":"Kinetic preference for interaction of cisplatin with the G-C-rich wobble basepair region in both tRNAAla and MhAla","volume":"29","author":"Papsai","year":"2006","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2024.117077_bib76","doi-asserted-by":"crossref","first-page":"11977","DOI":"10.1021\/ja111082e","article-title":"Platinum interference with siRNA non-seed regions fine-tunes silencing capacity","volume":"133","author":"Hedman","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.117077_bib77","doi-asserted-by":"crossref","first-page":"14959","DOI":"10.1039\/c3dt51788h","article-title":"Time dependence of cisplatin-induced duplex dissociation of 15-mer RNAs and mature miR-146a","volume":"42","author":"Polonyi","year":"2013","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2024.117077_bib78","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1021\/cb200279p","article-title":"RNA-Pt adducts following cisplatin treatment of Saccharomyces cerevisiae","volume":"7","author":"Hostetter","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.117077_bib79","doi-asserted-by":"crossref","first-page":"11680","DOI":"10.1021\/ja402453k","article-title":"Picazoplatin, an azide-containing platinum(II) derivative for target analysis by click chemistry","volume":"135","author":"White","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.117077_bib80","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1021\/cb500395z","article-title":"Platinum-RNA modifications following drug treatment in S. cerevisiae identified by click chemistry and enzymatic mapping","volume":"9","author":"Osborn","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.117077_bib81","article-title":"Overcoming cancer chemoresistance through chromatin compaction with orally platinum-based ACLY inhibitors","author":"Wang","year":"2024","journal-title":"CCS Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib82","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","article-title":"Mitochondria as multifaceted regulators of cell death","volume":"21","author":"Bock","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2024.117077_bib83","doi-asserted-by":"crossref","first-page":"8020","DOI":"10.1021\/acs.jmedchem.4c00144","article-title":"Glycyrrhetinic acid as a hepatocyte targeting ligandfunctionalized platinum(IV) complexes for hepatocellular carcinoma therapy and overcoming multidrug resistance","volume":"67","author":"Huang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib84","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1158\/2159-8290.CD-12-0231","article-title":"Oncogenic and wild-type Ras play divergent roles in the regulation of mitogen-activated protein kinase signaling","volume":"3","author":"Young","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2024.117077_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112269","article-title":"Targeting RAS-RAF pathway significantly improves antitumor activity of Rigosertib-derived platinum(IV) complexes and overcomes cisplatin resistance","volume":"194","author":"Liu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib86","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.semcancer.2017.11.008","article-title":"Matrix Metalloproteinases: a challenging paradigm of cancer management","volume":"56","author":"Alaseem","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejmech.2024.117077_bib87","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ejmech.2016.10.031","article-title":"Novel phenylenediamine bridged mixed ligands dimetallic square planner Pt(II) complex inhibits MMPs expression via p53 and caspase-dependent signaling and suppress cancer metastasis and invasion","volume":"125","author":"Rahman","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib88","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/cr.2017.155","article-title":"Mitochondrial metabolism and cancer","volume":"28","author":"Porporato","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2024.117077_bib89","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nchembio.1712","article-title":"Targeting mitochondria metabolism for cancer therapy","volume":"11","author":"Weinberg","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.117077_bib90","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrd4002","article-title":"Modulation of oxidative stress as an anticancer strategy","volume":"12","author":"Gorrini","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.117077_bib91","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1002\/anie.201900387","article-title":"Restraining cancer cells by dual metabolic inhibition with a mitochondrion-targeted platinum(II) complex","volume":"58","author":"Wang","year":"2019","journal-title":"Angew. Chem., Int. Ed."},{"issue":"2","key":"10.1016\/j.ejmech.2024.117077_bib92","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41556-018-0244-7","article-title":"The lysosome as a cellular centre for signalling, metabolism and quality control","volume":"21","author":"Lawrence","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejmech.2024.117077_bib93","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13045-021-01087-1","article-title":"Role of lysosomes in physiological activities, diseases, and therapy","volume":"14","author":"Zhang","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejmech.2024.117077_bib94","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1039\/D2DT02455A","article-title":"Antitumor effects of new glycoconjugated PtII agents dual-targeting GLUT1 and Pgp proteins","volume":"51","author":"Zhang","year":"2022","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2024.117077_bib95","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1039\/D3DT03598K","article-title":"A monofunctional Pt(II) complex combats triple negative breast cancer by triggering lysosome-dependent cell death","volume":"53","author":"Shen","year":"2024","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2024.117077_bib96","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1038\/s41388-024-03043-y","article-title":"Suppression of lysosome metabolism-meditated GARP\/TGF-\u03b21 complexes specifically depletes regulatory T cells to inhibit breast cancer metastasis","volume":"43","author":"Ma","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2024.117077_bib97","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","article-title":"Endoplasmic reticulum stress signals in the tumour and its microenvironment","volume":"21","author":"Chen","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2024.117077_bib98","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/156652406775574604","article-title":"ER stress, hypoxia tolerance and tumor progression","volume":"6","author":"Koumenis","year":"2006","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ejmech.2024.117077_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104741","article-title":"Dual-target platinum(IV) complexes exhibit antiproliferative activity through DNA damage and induce ER-stress-mediated apoptosis in A549 cells","volume":"110","author":"Wang","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib100","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1021\/acs.jmedchem.3c02182","article-title":"Novel NF-\u03baB inhibitor-conjugated Pt(IV) prodrug to enable cancer therapy through ROS\/ER stress and mitochondrial dysfunction and overcome multidrug resistance","volume":"67","author":"Wang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib101","doi-asserted-by":"crossref","DOI":"10.1002\/chem.202302948","article-title":"Development of platinum complexes for tumor chemoimmunotherapy","volume":"30","author":"Jin","year":"2024","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2024.117077_bib102","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni.3558","article-title":"Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing","volume":"17","author":"Chen","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejmech.2024.117077_bib103","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12943-020-01247-w","article-title":"cGAS-STING pathway in cancer biotherapy","volume":"19","author":"Wang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2024.117077_bib104","article-title":"Combining cisplatin and a STING agonist into one molecule for metalloimmunotherapy of cancer","volume":"11","author":"Zhang","year":"2024","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.ejmech.2024.117077_bib105","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12943-018-0915-9","article-title":"BRD4 and cancer: going beyond transcriptional regulation","volume":"17","author":"Donati","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2024.117077_bib106","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1021\/acs.nanolett.0c04402","article-title":"Synergistic therapy for cervical cancer by codelivery of cisplatin and JQ1 inhibiting Plk1-mutant Trp53 axis","volume":"21","author":"Wang","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejmech.2024.117077_bib107","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1021\/acs.jmedchem.2c01719","article-title":"CJ2: a novel potent platinum(IV) prodrug enhances chemoimmunotherapy by facilitating PD-L1 degradation in the cytoplasm and cytomembrane","volume":"66","author":"Fan","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib108","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2024.117077_bib109","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1021\/acs.jmedchem.3c01845","article-title":"Series of desloratadine platinum(IV) hybrids displaying potent antimetastatic competence by inhibiting epithelial\u2212mesenchymal transition and arousing immune response","volume":"67","author":"Zhang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-020-01258-7","article-title":"Targeting STAT3 in cancer immunotherapy","volume":"19","author":"Zou","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2024.117077_bib111","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/ni.3691","article-title":"Mechanisms and consequences of Jak-STAT signaling in the immune system","volume":"18","author":"Villarino","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejmech.2024.117077_bib112","doi-asserted-by":"crossref","first-page":"11351","DOI":"10.1021\/acs.jmedchem.3c00836","article-title":"Platinum(IV) complexes as inhibitors of STAT3 and regulators of the tumor microenvironment to control breast cancer","volume":"66","author":"Cai","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib113","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202112236","article-title":"Clinical development of metal complexes as photosensitizers for photodynamic therapy of cancer","volume":"61","author":"Karges","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2024.117077_bib114","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/anie.201905171","article-title":"New designs for phototherapeutic transition metal complexes","volume":"59","author":"Imberti","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2024.117077_bib115","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1039\/C9QI00738E","article-title":"Nucleus-localized platinum(II)\u2013triphenylamine complexes as potent photodynamic anticancer agents","volume":"6","author":"Zhong","year":"2019","journal-title":"Inorg. Chem. Front."},{"key":"10.1016\/j.ejmech.2024.117077_bib116","doi-asserted-by":"crossref","DOI":"10.1002\/asia.202300667","article-title":"Chakravarty, A platinum(II) boron-dipyrromethene complex for cellular imaging and mitochondria-targeted photodynamic therapy in red light","volume":"18","author":"Upadhyay","year":"2023","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.ejmech.2024.117077_bib117","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1039\/D3QI00327B","article-title":"Anti-myeloma pro-apoptotic Pt(II) diiodido complexes","volume":"10","author":"Masaryk","year":"2023","journal-title":"Inorg. Chem. Front."},{"key":"10.1016\/j.ejmech.2024.117077_bib118","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1021\/acs.jmedchem.3c00001","article-title":"Developing an anticancer platinum(II) compound based on the uniqueness of human serum albumin","volume":"66","author":"Zhang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib119","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/jcm9010084","article-title":"Tumor angiogenesis and anti-angiogenic strategies for cancer treatment","volume":"9","author":"Teleanu","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejmech.2024.117077_bib120","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1021\/acs.accounts.9b00283","article-title":"Smart nanotherapeutic targeting of tumor vasculature. Smart nanotherapeutic targeting of tumor vasculature","volume":"52","author":"Li","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2024.117077_bib121","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.2174\/092986709788453087","article-title":"The rational design of anticancer platinum complexes: the importance of the structure-activity relationship","volume":"16","author":"Monta\u00f1a","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117077_bib122","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","article-title":"The molecular machinery of regulated cell death","volume":"29","author":"Tang","year":"2019","journal-title":"Cell Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424009590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424009590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T15:18:40Z","timestamp":1733498320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424009590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":122,"alternative-id":["S0223523424009590"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117077","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA or not DNA \u2014that is the question determining the design of platinum anticancer drugs","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117077"}}